264 related articles for article (PubMed ID: 31281532)
1. Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers.
Yang X; Zhao J; Duan S; Hou X; Li X; Hu Z; Tang Z; Mo F; Lu X
Theranostics; 2019; 9(14):4066-4083. PubMed ID: 31281532
[No Abstract] [Full Text] [Related]
2. Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses.
He J; Duan S; Yu X; Qian Z; Zhou S; Zhang Z; Huang X; Huang Y; Su J; Lai C; Meng J; Zhou N; Lu X; Zhao Y
Theranostics; 2016; 6(5):752-61. PubMed ID: 27022421
[TBL] [Abstract][Full Text] [Related]
3. Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects.
Xie S; Hou X; Yang W; Shi W; Yang X; Duan S; Mo F; Liu A; Wang W; Lu X
Int J Nanomedicine; 2021; 16():6017-6034. PubMed ID: 34511903
[TBL] [Abstract][Full Text] [Related]
4. Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma.
Duan S; Song M; He J; Zhou N; Zhou S; Zhao J; Fang Y; Yi P; Huang X; Luo G; Lai C; Yu X; Zhang Z; Xie Y; Zhao Y; Lu X
J Biomed Nanotechnol; 2016 Apr; 12(4):700-9. PubMed ID: 27301196
[TBL] [Abstract][Full Text] [Related]
5. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.
Lai C; Yu X; Zhuo H; Zhou N; Xie Y; He J; Peng Y; Xie X; Luo G; Zhou S; Zhao Y; Lu X
J Biomed Nanotechnol; 2014 Dec; 10(12):3576-89. PubMed ID: 26000371
[TBL] [Abstract][Full Text] [Related]
7. Adoptive CD8
Liu S; Liu H; Song X; Jiang A; Deng Y; Yang C; Sun D; Jiang K; Yang F; Zheng Y
Nanoscale; 2021 Oct; 13(37):15789-15803. PubMed ID: 34528979
[TBL] [Abstract][Full Text] [Related]
8. CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.
Herrmann A; Priceman SJ; Swiderski P; Kujawski M; Xin H; Cherryholmes GA; Zhang W; Zhang C; Lahtz C; Kowolik C; Forman SJ; Kortylewski M; Yu H
J Clin Invest; 2014 Jul; 124(7):2977-87. PubMed ID: 24892807
[TBL] [Abstract][Full Text] [Related]
9. PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene.
Huang Y; Huang Y; He J; Wang H; Luo Y; Li Y; Liu J; Zhong L; Zhao Y
Biomaterials; 2019 Oct; 217():119231. PubMed ID: 31254933
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Endoglin-Single-Chain Variable Fragment/ Induced Protein 10 Fusion Protein Potently Boosts the Anti-Tumor Efficacy of Adoptively Transferred TRP2-Specific CD8
Li Y; Yang X; Lu X; Peng Z; Lai C; Xie S; Wei S; Yao H; Ding Z; Zhao X; Liu A; Hou X; Mo F
J Biomed Nanotechnol; 2020 Jul; 16(7):1119-1134. PubMed ID: 33308379
[TBL] [Abstract][Full Text] [Related]
11. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity.
Wang JY; Chen H; Dai SZ; Huang FY; Lin YY; Wang CC; Li L; Zheng WP; Tan GH
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35256516
[TBL] [Abstract][Full Text] [Related]
13. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
[TBL] [Abstract][Full Text] [Related]
14. A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models.
Jiao JG; Li YN; Wang H; Liu Q; Cao JX; Bai RZ; Huang FY
Dig Liver Dis; 2006 Aug; 38(8):578-87. PubMed ID: 16777500
[TBL] [Abstract][Full Text] [Related]
15. Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.
Ohmura Y; Yoshikawa K; Saga S; Ueda R; Kazaoka Y; Yamada S
Oncol Rep; 2008 May; 19(5):1265-70. PubMed ID: 18425386
[TBL] [Abstract][Full Text] [Related]
16. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
17. Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model.
Wang X; Zhang FC; Zhao HY; Lu XL; Sun Y; Xiong ZY; Jiang XB
Tumour Biol; 2014 Aug; 35(8):7781-91. PubMed ID: 24816916
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
19. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
20. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
